While there's growing evidence that psychedelic drugs can effectively treat severe mental health conditions, especially in cases where traditional treatments have failed, they still come with downsides. The company is using AI to help design psychedelic-like drugs that induce specific mental states without hallucinations, and its first compound looks promising. “We created the least psychedelic psychedelic that’s psychoactive,” says CEO Dillan DiNardo. It also produced psychoactive effects without inducing a mind-bending trip, which the company says is a validation of its AI platform. While participants reported heightened emotions, associative thinking, enhanced imagination, and perceptual effects such as colors looking brighter, they did not experience hallucinations, self-disintegration, oceanic boundlessness and other typical features of a psychedelic trip.